Sonomind
Develops ultrasound neuromodulation technology for treating depression for patients and psychiatric clinicians
Highlights
- Young companyFounded 2024
- New on EvolcAdded 2026-11-03
About Sonomind
Sonomind develops a non-invasive ultrasound neuromodulation approach intended to treat depression. Its technology uses a custom acoustic metalens to target deep brain regions.
The company addresses psychiatrists and patients, and also invites investor inquiries. It is based in Paris, France, and was founded in 2024. Its technology draws on research at the Physmed laboratory and licensed INSERM intellectual property.
Product: A non-invasive ultrasound neuromodulation system intended to target deep brain regions involved in depression.
Public tenders won
1 tender won since 1 Jan 2024 from 1 public buyer in France, worth €186k as awarded. From EU award notices (TED) that name Sonomind by its registry number.
- 28 Sep 2026 INSERM - Délégation Régionale Paris-IDF Centre-Est · Acquisition de deux systèmes de neurostimulation ultrasonore · €186k notice
Jobs at Sonomind
More health & medtech companies
Sonoscanner
Develops and sells portable and stationary ultrasound scanners for medical professionals and hospitalsNew on EvolcSophysa
Medical devices for cerebrospinal fluid management and neuromonitoring for healthcare specialistsNew on EvolcSounduct
Prescription bone-conduction hearing devices for hearing-care professionals and their patientsNew on EvolcSpimed-AI
AI software for cardiologists and radiologists to analyze coronary CT angiography scansNew on EvolcSpinem Robotics
Develops Odysseus, a spinal surgery robot with an attachable tracking system, for spine surgeonsYoung companyNew on EvolcSpineway
Designs and manufactures spinal implants and surgical instruments for surgeons and healthcare providers worldwideNew on EvolcRemote-friendly
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content management
- ElementorHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.